Sangamo Therapeutics Inc(SGMO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SGMO Sangamo Therapeutics Inc

休市中 12-06 16:00:00 EST

2.01

+0.04

+2.03%

盘后2.06

+0.05+2.49%

19:59 EST

最高2.08	最低1.92	成交量422.10万
今开2.00	昨收1.97	日振幅8.12%
总市值4.19亿	流通市值4.10亿	总股本2.09亿
成交额848.58万	换手率2.07%	流通股本2.04亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SGMO","market":"US","secType":"STK","nameCN":"Sangamo Therapeutics Inc","latestPrice":2.01,"timestamp":1733518800000,"preClose":1.97,"halted":0,"volume":4220954,"hourTrading":{"tag":"盘后","latestPrice":2.06,"preClose":2.01,"latestTime":"19:59 EST","volume":225132,"amount":454663.7787,"timestamp":1733533187283},"delay":0,"floatShares":204036838,"shares":208646870,"eps":-0.696669,"marketStatus":"休市中","marketStatusCode":7,"change":0.04,"latestTime":"12-06 16:00:00 EST","open":2,"high":2.08,"low":1.92,"amount":8485778.9074944,"amplitude":0.081218,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.696669,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1733734800000},"adr":0,"listingDate":954993600000,"adjPreClose":1.97,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2,"preClose":1.97,"latestTime":"09:29 EST","volume":29297,"amount":58637.8371011,"timestamp":1733495399906},"postHourTrading":{"tag":"盘后","latestPrice":2.06,"preClose":2.01,"latestTime":"19:59 EST","volume":225132,"amount":454663.7787,"timestamp":1733533187283},"volumeRatio":0.9623433518839244,"impliedVol":1.5733,"impliedVolPercentile":0.3294},"requestUrl":"/m/hq/s/SGMO","defaultTab":"news","newsList":[{"id":"2489852237","title":"Sangamo Therapeutics, Inc.盘中异动 早盘大幅拉升5.08%报2.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489852237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489852237?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:40","pubTimestamp":1733499650,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时40分，Sangamo Therapeutics, Inc.股票出现异动，股价急速拉升5.08%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120623405098e5e4ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120623405098e5e4ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SGMO","BK4139","BK4556"],"gpt_icon":0},{"id":"2485321469","title":"Sangamo Therapeutics, Inc.盘中异动 快速下跌5.08%报1.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485321469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485321469?lang=zh_cn&edition=full","pubTime":"2024-11-23 04:59","pubTimestamp":1732309149,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日04时59分，Sangamo Therapeutics, Inc.股票出现异动，股价快速跳水5.08%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112304590998e443ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112304590998e443ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMO","BK4139","LENZ","BK4556"],"gpt_icon":1},{"id":"2484819508","title":"BUZZ-Sangamo Therapeutics 在 FDA 批准开始疼痛治疗试验的申请后上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2484819508","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484819508?lang=zh_cn&edition=full","pubTime":"2024-11-20 18:55","pubTimestamp":1732100130,"startTime":"0","endTime":"0","summary":"BUZZ-Sangamo Therapeutics 在 FDA 批准开始疼痛治疗试验的申请后上涨11月20日 -  ** 基因组医疗公司Sangamo Therapeutics SGMO.O股价盘前上涨12.24%，至2.20美元 ** 该公司称  美国食品和药物管理局已批准该公司启动ST-503人体试验的申请 ** SGMO计划于2025年中期开始招募ST-503早中期研究的患者 ** 正在研究ST-503治疗特发性小纤维神经病引起的难治性疼痛，这是一种慢性神经痛。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241120:nL4T3MR0OR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","SGMO","BK4139"],"gpt_icon":0},{"id":"2484660915","title":"Sangamo Therapeutics, Inc.盘中异动 股价大跌9.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484660915","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484660915?lang=zh_cn&edition=full","pubTime":"2024-11-19 01:27","pubTimestamp":1731950853,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日01时27分，Sangamo Therapeutics, Inc.股票出现波动，股价急速下挫9.76%。截至发稿，该股报1.85美元/股，成交量255.523万股，换手率1.22%，振幅9.76%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119012734abccf811&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119012734abccf811&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMO","BK4139","BK4556","LENZ"],"gpt_icon":0},{"id":"2483804261","title":"Sangamo Therapeutics, Inc.盘中异动 早盘股价大跌5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483804261","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483804261?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:46","pubTimestamp":1731595604,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时46分，Sangamo Therapeutics, Inc.股票出现异动，股价急速下跌5.53%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224644a237da8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224644a237da8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SGMO","BK4139","BK4556"],"gpt_icon":0},{"id":"2483588109","title":"Sangamo Therapeutics, Inc.盘中异动 早盘股价大跌9.96%报2.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483588109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483588109?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:31","pubTimestamp":1731508288,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时31分，Sangamo Therapeutics, Inc.股票出现异动，股价急速跳水9.96%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322312895be2320&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322312895be2320&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMO","LENZ","BK4139","BK4556"],"gpt_icon":0},{"id":"2482746613","title":"Sangamo Therapeutics Inc  预计每股亏损 3 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482746613","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482746613?lang=zh_cn&edition=full","pubTime":"2024-11-09 08:11","pubTimestamp":1731111068,"startTime":"0","endTime":"0","summary":"Sangamo Therapeutics Inc  预计每股亏损 3 美分 - 财报前瞻Sangamo Therapeutics Inc SGMO.OQ SGMO.O将于11月12日公布截至2024年9月30日的财报，预计该公司的季度收入将有所增长。LSEG 分析师对 Sangamo Therapeutics Inc 的平均预期是每股亏损 3 美分。华尔街对 Sangamo Therapeutics Inc 的 12 个月目标价中位数为 3.00 美元，高于其上次收盘价 2.87 美元。11月9日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241109:nL4S3MG00J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMO"],"gpt_icon":0},{"id":"2481985790","title":"Sangamo Therapeutics, Inc.盘中异动 早盘大幅跳水5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481985790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481985790?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:36","pubTimestamp":1730903763,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时36分，Sangamo Therapeutics, Inc.股票出现波动，股价快速下跌5.32%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223604a21d2cea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223604a21d2cea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMO","LENZ","BK4139","BK4556"],"gpt_icon":0},{"id":"2481876500","title":"Sangamo Therapeutics, Inc.盘中异动 早盘股价大涨6.32%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481876500","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481876500?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:30","pubTimestamp":1730817035,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时30分，Sangamo Therapeutics, Inc.股票出现波动，股价快速拉升6.32%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223035aba23ace&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223035aba23ace&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4556","SGMO"],"gpt_icon":0},{"id":"2480581113","title":"Sangamo Therapeutics, Inc.盘中异动 急速跳水5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480581113","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480581113?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:41","pubTimestamp":1730731262,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时41分，Sangamo Therapeutics, Inc.股票出现波动，股价快速下跌5.32%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422410298e4049e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422410298e4049e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMO","LENZ","BK4139","BK4556"],"gpt_icon":0},{"id":"2480889106","title":"Sangamo Therapeutics, Inc.盘中异动 早盘快速上涨5.70%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480889106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480889106?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:30","pubTimestamp":1730467853,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时30分，Sangamo Therapeutics, Inc.股票出现异动，股价大幅拉升5.70%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121305398e3ffc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121305398e3ffc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMO","BK4139","BK4556","LENZ"],"gpt_icon":1},{"id":"2479038598","title":"Sangamo Therapeutics, Inc.盘中异动 大幅跳水5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479038598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479038598?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:36","pubTimestamp":1730381789,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时36分，Sangamo Therapeutics, Inc.股票出现波动，股价急速下挫5.53%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.35%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121362998e3fb47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121362998e3fb47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4556","SGMO","BK4139"],"gpt_icon":0},{"id":"2479228350","title":"Sangamo Therapeutics, Inc.盘中异动 大幅上涨9.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479228350","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479228350?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:33","pubTimestamp":1730208781,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时33分，Sangamo Therapeutics, Inc.股票出现波动，股价急速拉升9.73%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921330195bd8239&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921330195bd8239&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4556","LENZ","SGMO"],"gpt_icon":0},{"id":"2479415092","title":"Sangamo Therapeutics Inc    预计每股亏损 3 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2479415092","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479415092?lang=zh_cn&edition=full","pubTime":"2024-10-29 11:08","pubTimestamp":1730171321,"startTime":"0","endTime":"0","summary":"   * Sangamo Therapeutics Inc    预计将在10月30日公布截至2024年9月30日的业绩报告时显示季度收入增长()    * 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于加利福尼亚州里士满的公司的营收有望从去年同期的940万美元增长90.9%，达到1794.3万美元。* LSEG 分析师对 Sangamo Therapeutics Inc 的平均预期是每股亏损 3 美分。* 华尔街对 Sangamo Therapeutics Inc 的 12 个月目标价中位数为 3.00 美元，高于其上次收盘价 2.04 美元。10月29日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","SGMO"],"gpt_icon":1},{"id":"2478748961","title":"Sangamo Therapeutics, Inc.盘中异动 早盘股价大涨7.00%报1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478748961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478748961?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:31","pubTimestamp":1730122302,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时31分，Sangamo Therapeutics, Inc.股票出现波动，股价快速上涨7.00%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821314295bd7510&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821314295bd7510&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4556","SGMO"],"gpt_icon":0},{"id":"2477631905","title":"Sangamo Therapeutics, Inc.盘中异动 早盘大幅上涨5.84%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477631905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477631905?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:31","pubTimestamp":1729776698,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时31分，Sangamo Therapeutics, Inc.股票出现异动，股价急速拉升5.84%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421313895bd4d58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421313895bd4d58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMO","BK4139","LENZ","BK4556"],"gpt_icon":0},{"id":"2477533801","title":"Sangamo Therapeutics, Inc.股价飙升16.52% 市值涨4849.78万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477533801","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477533801?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:33","pubTimestamp":1729690382,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时33分，Sangamo Therapeutics, Inc.股票出现波动，股价大幅上涨16.52%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321330295bd42f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321330295bd42f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMO","BK4139","LENZ","BK4556"],"gpt_icon":0},{"id":"2477352553","title":"BUZZ--美国股票走势-洛克希德马丁公司、通用汽车公司、菲利普莫里斯国际公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2477352553","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477352553?lang=zh_cn&edition=full","pubTime":"2024-10-22 23:53","pubTimestamp":1729612383,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      10月22日 - 周二美国股指下挫，原因是国债收益率上升影响了对利率敏感的行业，同时投资者通过评估收益来评估美国公司的健康状况。美东时间11:32，道琼斯工业平均指数  下跌0.2%，报42860.24点。标普500指数  下跌0.22%，报5840.9点；纳斯达克综合指数  下跌0.08%，报18524.375点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UDOW","FSLR","DDM","DJX","QLD","MRCC","MNQmain","IPG","NUE","GPC",".SPX","IPAR","ASPN","RTX","LMT","CRVS","ZETA","KMB","SHW",".DJI","IMUX","NSC","SQQQ","TQQQ","ZION","PII","LEGN","TXN","SGMO",".IXIC","PTON","WRB","FCX","CORZ","MGRX","SDOW","DHR","AOS","PCAR","DGX","CSIQ","MMM","PSQ","CAKE","MCO","CDE"],"gpt_icon":1},{"id":"2477535970","title":"BUZZ-Sangamo 因 FDA 表示基因疗法加速审批无需额外研究而大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2477535970","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477535970?lang=zh_cn&edition=full","pubTime":"2024-10-22 23:19","pubTimestamp":1729610354,"startTime":"0","endTime":"0","summary":" (更新)    10月22日 - ** 基因组医疗公司Sangamo Therapeutics   股价上涨 33.6%，达到1.22美元的8个多月新高** 该公司称，美国食品和药物管理局已同意将正在进行的早中期研究数据作为加速批准其治疗法布里病的实验性基因疗法的主要依据** 据古根海姆分析师称，FDA 的反馈意见表明，该机构 \"在寻求广泛推进基因疗法的过程中具有监管灵活性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SGMO","BK4556"],"gpt_icon":0},{"id":"2477337503","title":"Sangamo Therapeutics, Inc.股价拉升34.72% 市值涨8892.17万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477337503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477337503?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:30","pubTimestamp":1729603805,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日21时30分，Sangamo Therapeutics, Inc.股票出现异动，股价快速上涨34.72%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Sangamo Therapeutics, Inc.、Tnf Pharmaceuticals, Inc.、Fortress Biotech, Inc.涨幅较大，Genprex, Inc.、Tc Biopharm  Plc、Ensysce Biosciences, Inc.较为活跃，换手率分别为1641.66%、1105.46%、997.83%，振幅较大的相关个股有Os Therapies Incorporated、Voyager Therapeutics, Inc.、Ocugen, Inc.，振幅分别为1.00%、0.91%、0.40%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022213005971a1981&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022213005971a1981&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4556","LENZ","SGMO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sangamo.com","stockEarnings":[{"period":"1week","weight":-0.1106},{"period":"1month","weight":-0.1862},{"period":"3month","weight":1.7801},{"period":"6month","weight":2.4999},{"period":"1year","weight":3.3934},{"period":"ytd","weight":2.6996}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0284},{"period":"3month","weight":0.1248},{"period":"6month","weight":0.1382},{"period":"1year","weight":0.3264},{"period":"ytd","weight":0.2788}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sangamo Therapeutics, Inc.是于1995年6月22日在特拉华州注册成立，专注于为基因调控和基因修饰的新型转录因子的开发和商业化。 该公司是一个临床阶段的生物制药公司，侧重于对未满足的医疗需要的新的治疗策略-DNA结合蛋白的研究，开发和商业化。目前，该公司的科学和业务发展的工作集中在新型锌指DNA结合蛋白工程的基因调控和修改。该公司的战略是通过早期临床试验阶段和与生物制药公司执行后期临床试验和商业化发展的战略合作伙伴，来开发高度特异性的锌指蛋白核酸酶和锌指蛋白转录因子。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.060119},{"month":2,"riseRate":0.458333,"avgChangeRate":0.076653},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.058863},{"month":4,"riseRate":0.416667,"avgChangeRate":-0.009164},{"month":5,"riseRate":0.32,"avgChangeRate":-0.013157},{"month":6,"riseRate":0.4,"avgChangeRate":0.101912},{"month":7,"riseRate":0.52,"avgChangeRate":0.034174},{"month":8,"riseRate":0.56,"avgChangeRate":0.047528},{"month":9,"riseRate":0.48,"avgChangeRate":-0.042002},{"month":10,"riseRate":0.52,"avgChangeRate":0.00664},{"month":11,"riseRate":0.48,"avgChangeRate":0.062986},{"month":12,"riseRate":0.6,"avgChangeRate":0.064884}],"exchange":"NASDAQ","name":"Sangamo Therapeutics Inc","nameEN":"Sangamo Therapeutics Inc"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sangamo Therapeutics Inc(SGMO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Sangamo Therapeutics Inc(SGMO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Sangamo Therapeutics Inc,SGMO,Sangamo Therapeutics Inc股票,Sangamo Therapeutics Inc股票老虎,Sangamo Therapeutics Inc股票老虎国际,Sangamo Therapeutics Inc行情,Sangamo Therapeutics Inc股票行情,Sangamo Therapeutics Inc股价,Sangamo Therapeutics Inc股市,Sangamo Therapeutics Inc股票价格,Sangamo Therapeutics Inc股票交易,Sangamo Therapeutics Inc股票购买,Sangamo Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sangamo Therapeutics Inc(SGMO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Sangamo Therapeutics Inc(SGMO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}